Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Methodological Quality and Risk of Bias Assessment We used the Cochrane Risk of Bias 2 (RoB 2) tool (crossover extension where applicable) for assessing the risk of bias to evaluate the methodological quality of RCTs
When Tirzepatide Dose Reduction May Be Appropriate Your healthcare provider might suggest dose reduction if you're experiencing persistent nausea, vomiting, or gastrointestinal distress that limits your quality of life
"The Screening and Surveillance of Ultrasound in Melanoma trial (SUNMEL)"
Please reach out to the authors, your Foley relationship partner, our Health Care & Life Sciences Sector , or to our Innovative Technology Sector with any questions
US$ 24.25
US$ 20.31
US$ 28.65
US$ 21.47
US$ 22.50
